CBL114F
Mouse Anti-Human IgA Antibody, clone M24A, heavy chain, FITC conjugated
clone M24A, Chemicon®, from mouse
Szinonimák:
Anti-human IgA FITC
Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez
Összes fotó(1)
About This Item
UNSPSC kód:
12352203
eCl@ss:
32160702
NACRES:
NA.46
Javasolt termékek
biológiai forrás
mouse
Minőségi szint
konjugátum
FITC conjugate
antitest forma
purified immunoglobulin
antitest terméktípus
secondary antibodies
klón
M24A, monoclonal
faj reaktivitás
human
gyártó/kereskedő neve
Chemicon®
technika/technikák
ELISA: suitable
flow cytometry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
izotípus
IgG1
kiszállítva
wet ice
célzott transzláció utáni módosítás
unmodified
Egyediség
This antibody is specific for the heavy chain of human immunoglobulin A, and shows no cross-reactivity with intact human IgM or IgG, kappa or lambda light chains
Alkalmazás
Immunohistological staining of IgA expressing cells in tissue sections.
Identification of surface IgA on B lymphocytes by direct Immunofluorescence.
ELISA
Flow Cytometry
Optimal working dilutions must be determined by the end user.
Identification of surface IgA on B lymphocytes by direct Immunofluorescence.
ELISA
Flow Cytometry
Optimal working dilutions must be determined by the end user.
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Fragment Specific Secondary Antibodies
Fragment Specific Secondary Antibodies
This Mouse anti-Human IgA Antibody, clone M24A, heavy chain, FITC conjugated is validated for use in ELISA, FC, IF, IH for the detection of Human IgA.
Fizikai forma
The conjugate is supplied in phosphate buffered saline containing 10mM sodium azide and 1mg/ml bovine serum albumin. For flow cytometry we recommend using 10μL of conjugate per test.
Tárolás és stabilitás
Store at +4°C protected from light. DO NOT FREEZE. For long term use and storage aliquot conjugate into small volumes and store at +4°C for up to one year.
Jogi információk
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Jogi nyilatkozat
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Nem találja a megfelelő terméket?
Próbálja ki a Termékválasztó eszköz. eszközt
Tárolási osztály kódja
12 - Non Combustible Liquids
WGK
WGK 2
Lobbanási pont (F)
Not applicable
Lobbanási pont (C)
Not applicable
Analitikai tanúsítványok (COA)
Analitikai tanúsítványok (COA) keresése a termék sarzs-/tételszámának megadásával. A sarzs- és tételszámok a termék címkéjén találhatók, a „Lot” vagy „Batch” szavak után.
Már rendelkezik ezzel a termékkel?
Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.
Philip A Mudd et al.
Cell, 185(4), 603-613 (2022-01-14)
SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4+ T cell responses. It is not yet clear whether vaccine-induced follicular helper CD4+ T (TFH) cell responses contribute to this outstanding immunogenicity. Using fine-needle aspiration of draining axillary lymph nodes from
Jackson S Turner et al.
Nature, 595(7867), 421-425 (2021-05-25)
Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of protective antibodies1-7. Individuals who have recovered from COVID-19 have a substantially lower risk of reinfection with SARS-CoV-28-10. Nonetheless, it has been reported that levels of anti-SARS-CoV-2 serum
Jackson S Turner et al.
Nature, 596(7870), 109-113 (2021-06-29)
SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-191-5. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Alsoussi, et al.
Nature, 617, 592-598 (2023)
Joana P Bernardes et al.
Immunity, 53(6), 1296-1314 (2020-12-10)
Temporal resolution of cellular features associated with a severe COVID-19 disease trajectory is needed for understanding skewed immune responses and defining predictors of outcome. Here, we performed a longitudinal multi-omics study using a two-center cohort of 14 patients. We analyzed
Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.
Lépjen kapcsolatba a szaktanácsadással